Intraoperative cell salvage in revision hip arthroplasty.

Thomas J WaltonDaniel HuntleySarah L WhitehouseJennifer DaviesMatthew J Wilson Matthew J W Hubble Jonathan R Howell Al-Amin M Kassam

Published in: The bone & joint journal (2023)

We found a a significant reduction in the need for allogenic blood transfusion when cell salvage was used in patients undergoing revision hip arthroplasty, supporting its routine use in these patients. Further research is required to determine whether this effect is associated with types of revision arthroplasty of differing complexity.

Keyphrases

total hip arthroplasty
total knee arthroplasty
patients undergoing
single cell
end stage renal disease
cell therapy
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
stem cells
clinical practice